P L Alonso Selected Research

Malaria

12/2015	Sleeping arrangements and mass distribution of bed nets in six districts in central and northern Mozambique.
1/2007	Safety and immunogenicity of the RTS,S/AS02A candidate malaria vaccine in children aged 1-4 in Mozambique.
3/2006	Malaria: burden of disease.
2/2004	Efficacy of chloroquine, amodiaquine, sulphadoxine-pyrimethamine and combination therapy with artesunate in Mozambican children with non-complicated malaria.
11/2003	The incidence of clinical malaria detected by active case detection in children in Ifakara, southern Tanzania.
8/2001	Effect of malaria on soluble transferrin receptor levels in Tanzanian infants.
6/2001	Diagnostic accuracy and case management of clinical malaria in the primary health services of a rural area in south-eastern Tanzania.
4/2001	Prenatal risk factors of wheezing at the age of four years in Tanzania.
9/2000	Humoral immune responses during a malaria vaccine trial in Tanzanian infants.
1/2000	Cost-effectiveness of iron supplementation and malaria chemoprophylaxis in the prevention of anaemia and malaria among Tanzanian infants.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

P L Alonso Research Topics

Disease

10	Malaria 12/2015 - 01/2000
3	Infections 08/2001 - 01/2000
2	Pneumonia (Pneumonitis) 09/2012 - 07/2010
2	Asthma (Bronchial Asthma) 04/2001 - 08/2000
2	Hypertension (High Blood Pressure) 01/2001 - 01/2000
2	Pre-Eclampsia (Preeclampsia) 01/2001 - 01/2000
1	Pneumococcal Infections 10/2010
1	Fever (Fevers) 02/2004
1	Iron Deficiencies 08/2001
1	Iron-Deficiency Anemia (Anemia, Iron Deficiency) 08/2001
1	Respiratory Sounds (Crackle) 04/2001
1	Hypersensitivity (Allergy) 08/2000
1	Persistent Infection 01/2000
1	Pregnancy-Induced Hypertension (Hypertension, Pregnancy Induced) 01/2000

Drug/Important Bio-Agent (IBA)

3	IronIBA 08/2001 - 01/2000
2	VaccinesIBA 07/2010 - 01/2007
2	Chloroquine (Aralen)FDA LinkGeneric 03/2006 - 02/2004
2	Indicators and Reagents (Reagents)IBA 11/2003 - 08/2001
2	AllergensIBA 04/2001 - 08/2000
2	Immunoglobulin E (IgE)IBA 04/2001 - 08/2000
2	AntibodiesIBA 01/2001 - 08/2000
1	ProcalcitoninIBA 09/2012
1	C-Reactive ProteinIBA 09/2012
1	Mannose-Binding Lectin (Mannan-Binding Lectin)IBA 10/2010
1	Conjugate VaccinesIBA 07/2010
1	Polysaccharides (Glycans)IBA 07/2010
1	Proteins (Proteins, Gene)FDA Link 07/2010
1	ArtesunateIBA 02/2004
1	Amodiaquine (Camoquin)FDA Link 02/2004
1	pyrimethamine drug combination fanasil (Fansidar)FDA Link 02/2004
1	Transferrin Receptors (Transferrin Receptor)IBA 08/2001
1	Antimalarials (Antimalarial Agents)IBA 06/2001
1	low density lipoprotein inhibitorIBA 01/2001
1	oxidized low density lipoproteinIBA 01/2001
1	Lipid PeroxidesIBA 01/2001
1	Vitamin E FDA LinkGeneric 01/2001
1	Malaria VaccinesIBA 09/2000
1	Immunoglobulin G (IgG)IBA 09/2000
1	AntigensIBA 08/2000
1	Dermatophagoides pteronyssinus antigen p 1IBA 08/2000
1	inhibin AIBA 01/2000
1	Pyrimethamine (Daraprim)FDA Link 01/2000
1	hemozoinIBA 01/2000
1	FibrinIBA 01/2000
1	Dapsone FDA Link 01/2000

Therapy/Procedure

2	Chemoprevention 04/2001 - 01/2000
1	Insecticide-Treated Bednets 12/2015
1	Therapeutics 02/2004